Covid-19 News
October 01, 2021
Patients must receive the vaccine at participating community-based sites as listed on ShotFor100.com. Anyone receiving their first shot is eligible and may only participate once.
September 28, 2021
"There is no doubt that our COVID-19 situation in Louisiana has improved since the peak of our fourth surge, which was largely driven by the Delta variant, and for that I am deeply grateful," said Gov. Edwards. "Even so, the amount of COVID in Louisiana is still incredibly high, at 243 cases for every 100,000 people, as it is disproportionately driven by transmission in those five to 18 years old.
September 28, 2021
All 14 cases involved mothers who were unvaccinated, and resulted in 6 maternal deaths and 10 fetal deaths.
September 24, 2021
Effective immediately, booster shots of the Pfizer-BioNTech COVID-19 vaccine are available to adults at increased risk, following new guidance from the Centers for Disease Control and Prevention (CDC).
September 24, 2021
The Louisiana Department of Health is now operating 13 community-based monoclonal antibody therapy (mAb) treatment sites, including one in Baton Rouge, and is on track to open one additional site on Saturday.
September 22, 2021
The child was between the ages of 12 and 17. No further information will be released on this death.
September 20, 2021
Shreveport Mayor Adrian Perkins and Lake Charles Mayor Nic Hunter announced a friendly competition to see which city's residents could achieve the highest increase in first dose vaccinations of a COVID-19 vaccine by Sunday, October 31, 2021.
September 17, 2021
The Louisiana Department of Health is now operating six federally supported monoclonal antibody therapy (mAb) treatment sites and is on track to open two additional sites through September 25.
September 17, 2021
This brings the total of pediatric deaths during this fourth surge to 6. In total, 15 children younger than 18 have died from COVID in Louisiana.
September 13, 2021
Monoclonal antibodies are man-made antibodies produced in a laboratory that can mimic the human immune system response to infection. mAbs are designed to block viral attachment and entry into human cells, thus neutralizing the virus that causes COVID-19.